http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2241987-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2002-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8d972b17978915ed5486b58456e77f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0669240e692e6de073c686b86bb30a49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec59c6c1f8bf5419307c78c81569cf11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d8cec5f6e6c760e3b98c9014f2a37fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bf8079c68fb1917e9912cab02edf493 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa5e859fe252ff2e510a26f46a8b12dc |
| publicationDate | 2004-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2241987-C2 |
| titleOfInvention | Method for determining pathological process generalization in the cases of oncological diseases |
| abstract | FIELD: medicine. n SUBSTANCE: method involves determining chemoluminescence intensity and ceruloplasmin activity before beginning antitumor mammary carcinoma treatment in the cases of III-IV disease stage. Ratio coefficient of chemoluminescence intensity and ceruloplasmin activity being found 8-12 times as small when compared to healthy people, tumor development process generalization is considered to be the case. The value being found 2-3 times as low, no generalization is considered to be the case. n EFFECT: high accuracy and simplicity of the method. n 1 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2622756-C1 |
| priorityDate | 2002-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.